Neutral impactCompany
Kilitch Drugs (India) Limited — Corrigendum
NSE 7 hrs ago·12 Nov 2026, 1:47 pm
Kilitch Drugs IndiaKilitch Drugs (India) Limited has announced a corrigendum to the notice for its Extra Ordinary General Meeting (EGM). This update clarifies or corrects the details of the meeting, which is scheduled to be held on November 16, 2026.
This announcement is a standard corporate procedure to ensure all investors have the most accurate and up-to-date information regarding the company's governance agenda. For the average investor, this update does not alter the core business operations or financial outlook of the company.
Investors should wait for the full agenda details in the official corrigendum to understand the specific resolutions being proposed. Keeping an eye on the official exchange filings will help in tracking any further developments related to this meeting.
Affected stocks
Neutral1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Kilitch Drugs India (KILITCH).
- Category: Company.
Why it matters
A routine update for Kilitch Drugs India. Use the price and stock snapshot to gauge how the market is responding.
